1. Stocks
  2. Cyclerion Therapeutics Inc
  3. Swot
swot-logo

Cyclerion Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Cyclerion Therapeutics Inc has 13 Strengths, 7 Weaknesses, 4 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout First Resistance ( LTP > R1)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Increasing profits every quarter for the past four quarters

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Increasing profits every quarter for the past 4 quarters

Positive Breakout (LTP > R1)

Top Gainers

Stock with Low PE (PE < = 10)

Highest Recovery from 52 Week Low

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Institutions decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks